Second Congress of the Romanian Society of Bone Marrow Transplantation
|
|
|
- Philippa Walker
- 5 years ago
- Views:
Transcription
1 Second Congress of the Romanian Society of Bone Marrow Transplantation March 2018 Caro Hotel, Bucharest 14 March 2018 (Wednesday) Opening ceremony Dinner 15 March 2018 (Thursday) Day 1: Updates on Hot Topics in Hematopoietic Stem Cell Transplantation Registration Session 1. Myeloid Neoplasms - Chair Ștefan Ciurea Ștefan Ciurea: Selection of Graft Source for Haploidentical SCT Nicolas Kroger: Update on Allogeneic SCT for MPNs Didier Blaise: Update on Allogeneic SCT for AML Robert Gale Update on MRD in AML Coffee break 11:15 13:15 Session 2. Lymphoma and GVHD - Chair: Ernst Holler Luca Castagna Allogeneic Transplantion for non-hodgkin Lymphomas Ernst Holler What s New in GVHD? Leo Luznik PTCy as GVHD prophylaxis - Is it Suitable for All Types of Allotransplants? Anna Sureda Allogeneic Transplantation for Hodgkin Disease in the Era of Novel Agents
2 Lunch Janssen Symposia: Dominik Dytfeld - The Rationale and Clinical Data for Monoclonal Antibodies in Multiple Myeloma Session 3. Pediatric Session - Chair: Donald Small Gergely Krivan Clinical Experience with Antigen-Specific T Cell Therapy in Budapest Donald Small - FLT3: Biology and Role of BMT Coffee Break Takeda Symposia: Anna Sureda - Brentuximab Vedotin The First Consolidation Therapy Post ASCT in Hodgkin Lymphoma: Who, When and How to Treat Ciprian Tomuleasa: How to Obtain a Research Grant in Hematology? MSD Symposia: Janos Sinko - Prophylactic Anti-Infective Strategies in Allogeneic Stem Cell Transplantation: Focus on Aspergillosis and Cytomegalovirus Reactivation Poster Session 1. Bone Marrow Transplantation at the Iași Regional Oncology Institute: A Report on the First Two Procedures Ion Antohe, Elena Ghiata, Amalia Titieanu, Florina Farca, Cristina Burcoveanu, Cătălin Dănăilă, Angelica Dăscălescu 2. HLA-DPB1 Typing in the Selection of a Compatible Unrelated Hematopoietic Stem Cells Donor: a Retrospective Study O.Toma, Ruxandra Caisan, Zsofia Varady, Alina Tanase, Anca Colița, Lorena Ulea, L.Jieanu, A. Șerban, Monica Duțescu 3. Acute Myeloblastic Leukemia - LAM1 in the Patient with a History of Hodgkin's Lymphoma
3 Iuliana Maria Nicorescu, Daniela Georgeta Georgescu, Marius Balea et all 4. The Right Moment for Stem Cell Transplantation in One Case of Refractory High Risk AML M4 Daniela Georgeta Georgescu, Marius Balea, Oana Pătrinoiu, Mihaela Popescu, Rodica Gogulescu 16 March 2018 (Friday) Day 2: Romanian Perspectives in Hematopoietic Stem Cell Transplantation Registration 09:00 11:30 Session 4. Chair: Gabriel Ghiaur: Acute Leukemias When to Transplant? Romanian key opinion leaders in hematology discuss indications to transplantation: Delia Dima - Challenges in Diagnosis In Acute Leukemia in Romania Mihaela Andreescu - Optimizing Treatment in Acute Leukemias in Order to Prepare the Patient for Transplantation Andrei Coliță - Acute Myeloid Leukemia in Patients > 60 Years - (When) Should We Transplant? Ana Maria Vlădăreanu - Acute Leukemias Secondary to Myelodysplastic Syndromes - Particular Aspects of Diagnosis and Treatment Horia Bumbea - The role of Minimal Residual Disease in Allogeneic SCT Angelica Dăscălescu - Treatment Outcome with and without Transplantation Anca Colița - Acute Leukemia in Children Transplant Indications Ionela Rotaru - Acute Leukemia Diagnosis and Treatment in Craiova University Hospital Ioan Macarie - Acute Leukemia Diagnosis and Treatment in Târgu Mureș University Hospital Gabriel Ghiaur Take Home Messages Coffee Break
4 Pfizer Symposia: Alina Tănase - Redefining outcomes in R/R ALL Novartis Symposia: Andrei Coliță - Rydapt (Midostaurin) Changing Treatment Paradigm in Acute Myeloid Leukemia Novartis Symposia: Andrei Coliță - Rydapt (Midostaurin) Changing Treatment Paradigm in Acute Myeloid Leukemia Lunch Session 5. Lessons Learned from Case Reports (Educational Session) Panel discussion: Alina Tănase, Anca Coliță, Erzebeth Lazăr Benedek, Smaranda Arghirescu, Angelica Dăscălescu, Andrei Coliță - 9 cases Indication for Allogeneic Hematopoietic Stem Cell Transplantation in Adult T Cell Leukemia/Lymphoma: Report of Two Cases Daniela Ogreanu, Oana Gabriela Crăciun, Laura Diana Ștefan, Lavinia Eugenia Lipan, Andra Jugănaru, Roxana Dragan, Alina Tănase Juvenile Myelomonocytic Leukemia When to Transplant? Cristina Jercan, Andreea Șerbănica, Andra Beldiman, Letiția Radu, Mihaela Safta, Ana Maria Bică, Mirela Asan, Anca Gheorghe, Codruța Popa, Monica Duțescu, Carmen Călugăroiu, Alexandra Ionete, Ligia Barbarii, Carmen Constantinescu, Ileana Constantinescu, Anca Coliță Autologous Stem Cell Transplantation for T/Nk Lymphoma Complicated With Hemophagocytic Lymphohistiocytosis Andrei Coliță, Raluca Manolache, Cecilia Ghimici, Carmen Șaguna, Doina Barbu, Florentina Grădinaru, Silvana Angelescu, Anca Coliță, Alina Tănase, Zsofia Varady, Alexandra Ionete, Ileana Constantinescu, Anca Lupu Lymphoproliferative Sindrom after Autologous Stem Cell Transplant for Angioimmunoblastic Lymphoma Mihaela Popescu, Laura Diana Ștefan, Camelia Dobrea Allogeneic Stem Cell Transplant in a 64 Years Old Patient with Acute Myeloid Leukemia Oana Crăciun, Diana Laura Ștefan, Daniela Ogreanu, Lavinia Lipan, Monica Dragomir, Leny Caban, Alina Tănase Hematopoietic Stem Cell Transplant in Young Patients with Multiple Myeloma Erzebeth Lazăr Benedek
5 Haploidentical Stem Cell Transplant Transplant as Second Allogeneic Transplant Zsofia Varady, Oana Crăciun, Laura Diana Ștefan, Ana Maria Moldovianu, Alexandra Ionete, Călugăroiu C, Lavinia Lipan, Monica Duțescu, Ruxandra Caisan, Lorena Ulea, Ileana Constantinescu, Ana Moise, L. Jieanu, T. Pușcasu, L. Arghișan, Aurora Dragomirișteanu, Daniel Coriu, Alina Tănase Hematopoietic Stem Cell Transplant in Refractory Hodgkin Disease Angelica Dăscălescu, Ion Antohe, Elena Ghiata Biphenotypic Acute Leukemia and Granulocytic Mediastinal Sarcoma. Agresiv Cytostatic Treatment and Peripheral Stem Cell Allotransplant. Alina Catana, Lazăr Benedek Erzebeth, Ioan Manițiu, Miclea Ion, Dobrea Camelia, Gabriela Cocisiu, Liliana Mocanu, Ioan Zaharia, Romeo Mihăila, Tania Olariu, Mariana Sandu, Dina Dobra, Cristina Noor, Lidia-Maria Mondoc, Andreea Antal Coffee Break Session 6. Nursing Challenges in Care of Stem Cell Transplant Patients - Chair: Erik Aerts Nursing Challenges in Stem Cell Transplantation Patients Erik Aerts Most Common Complications in Allotransplanted Patients Adriana Buzatu Specific Management Aspects in Care of Bone Marrow Transplant Patients Dumitra Macoveanu, Nuși Stanciu Allotransplantation with a Haploidentical Donor - a Chance for Survival for Patients with Advanced Hematological Diseases Alexandru Bucur, Georgeta Tudor Vascular Access Devices Used in Stem Cell Transplanted Patients Georgeta Tudor, Mihaela Silvia Moldoveanu Communication with the Oncology Patient Gabriela Meșter Mucositis in Patients with Autologous Stem Cell Transplant - Experience of Iași Transplant Center Florina Farca, Oana Chițescu, Viorel Dănăila, Oana Crețu
6 The Importance of Quality of Life in Patients Receiving Stem Cell Transplant Oana Lupu Rare Complications Following Stem Cell Transplantation - BK Virus/Hemorragic Cystitis Daniela Radu, Loredana Bostan, Elena Toma, Oana Otilia Niculiță Nosocomial Infections in Stem Cell Transplanted Patients Elena Toporaș, Elena Călin, Oana Otilia Niculiță Aplastic Anemia - Specific Nursing Care Issues Laura Marin, Petruța Cioflan, Oana Otilia Niculiță Closing Ceremony
The First National Congress of the Romanian Society of Bone Marrow Transplant - Bone Marrow Transplant A Life-Saving Treatment -
The First National Congress of the Romanian Society of Bone Marrow - Bone Marrow A Life-Saving Treatment - 19 th -21 st of June, 2017, Ramada Parc Hotel, Bucharest SCIENTIFIC PROGRAMME Monday, 19.06.2017
Honorary President: Prof. Dr. Kenneth Eaton - England Presidents: Prof. Dr. Corneliu Amariei
23 25 Mai 2012 CONSTANTA, ROMANIA THE X TH INTERNATIONAL CONGRESS OF ORO-DENTAL HEALTH AND MANAGEMENT IN THE BLACK SEA EURO-REGION Honorary President: Prof. Dr. Kenneth Eaton - England Presidents: Prof.
PRELIMINARY SCIENTIFIC PROGRAM :50 Meet the experts- Molecular mechanisms in IBD from basic science to therapy. Franco-Romanian Meeting
PRELIMINARY SCIENTIFIC PROGRAM RCCC Annual Meeting 27th-29th of SEPEMBER 2018 Thursday 27 th of September 2018 7.30-8.00 Registration 8.00-9:50 Meet the experts- Molecular mechanisms in IBD from basic
SCIENTIFIC PROGRAM Pharma Symposium Takeda: Changing the Game in IBD. Speakers: Bogdan Mateescu, Lucian Negreanu
SCIENTIFIC PROGRAM RCCC Annual Meeting 28 th -30 th of SEPEMBER 2017 Thursday 28 th of September 2017 ECCO educational workshop 17.30-18.30 Pharma Symposium Takeda: Changing the Game in IBD. Speakers:
Iulia Ursuleac, University of Medicine and Pharmacy Carol Davila, Bucharest, Fundeni Clinical Institute, Bucharest, Romania Luminița Rusen,
Nr. XXXIV, Vol. 1-2, 2015 Editor-in-Chief Daniel Coriu University of Pharmacy Carol Davila Bucharest, Fundeni Institute, Bucharest, Romania Deputy/ Managing Editor Radu Niculescu, Fundeni Clinical Institute,
Recommended Timing for Transplant Consultation
REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org
MUD SCT. Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University
MUD SCT Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University Outlines Optimal match criteria for unrelated adult donors Role of ATG in MUD-SCT Post-transplant
Saturday, 5 December 2015 Ramada Parc Hotel, Conference Hall 1
Saturday, 5 December 2015 Ramada Parc Hotel, Conference Hall 1 08.30-08.40 Opening Ceremony 08.40-10.40 Session I Multidisciplinary Approach of Metabolic Syndrome Ciprian Duţă (Timişoara, Romania) Nicolae
3 rd EBMT International Transplant Course
3 rd EBMT International Transplant Course 07 th 9 th September 2018, University of Barcelona, Faculty of Medicine Carrer de Casanova 143, 08036 Barcelona, Spain #EBMTITC18 EBMT International WELCOME It
SCIENTIFIC PROGRAM. The First Franco-Romanian Meeting
SCIENTIFIC PROGRAM RCCC Annual Meeting 27 th -29 th of September 2018 The First Franco-Romanian Meeting Thursday 27 th of September 2018 7.30-8.15 Registration 8.15-9:45 Meet the experts The therapeutic
Clinical Policy: Donor Lymphocyte Infusion
Clinical Policy: Reference Number: PA.CP.MP.101 Effective Date: 01/18 Last Review Date: 11/16 Coding Implications Revision Log This policy describes the medical necessity requirements for a donor lymphocyte
The 10th National Symposium on Inflammatory Bowel Diseases
1958 The 10 th National Symposium on Inflammatory Bowel Diseases Crowne Plaza Hotel, Bucharest, 27 th - 29 th of September 2018 The First Franco- Romanian Meeting Program www.rccc-congress.ro office.rccc@gmail.com
An Introduction to Bone Marrow Transplant
Introduction to Blood Cancers An Introduction to Bone Marrow Transplant Rushang Patel, MD, PhD, FACP Florida Hospital Medical Group S My RBC Plt Gran Polycythemia Vera Essential Thrombocythemia AML, CML,
Allogeneic Hematopoietic Stem Cell Transplantation: State of the Art in 2018 RICHARD W. CHILDS M.D. BETHESDA MD
Allogeneic Hematopoietic Stem Cell Transplantation: State of the Art in 2018 RICHARD W. CHILDS M.D. BETHESDA MD Overview: Update on allogeneic transplantation for malignant and nonmalignant diseases: state
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral
International Meeting dedicated to the memory of Raisa Gorbacheva. HEMOPOIETIC STEM CELLS TRANSPLANTATION Saint-Petersburg, September 21-22, 2007
International Meeting dedicated to the memory of Raisa Gorbacheva HEMOPOIETIC STEM CELLS TRANSPLANTATION Saint-Petersburg, September 21-22, 2007 Preliminary program September 21 Friday 8.00-8.30 - registration
PHYSICAL EXERCISES - A COMPLEX AND MODERN WAY TO PROMOTE HEALTHY LIVING
5 th INTERNATIONAL CONFERENCE PHYSICAL EXERCISES - A COMPLEX AND MODERN WAY TO PROMOTE HEALTHY LIVING 29-30 MARCH 2013 CRAIOVA ROMÂNIA Thursday, March, 28 th, 2013 14.00-16.00 - Arrivals And Registration
Dear colleagues and friends,
Dear colleagues and friends, After the last year s success, I am delighted to welcome you to the 2017 Bucharest PancreaticFest, which will take place at the Crowne Plaza Hotel in Bucharest, from the 8th
Introduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018
Introduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018 The transfer of hematopoietic progenitor and stem cells for therapeutic purposes Hematopoietic Cell
Dear Colleagues and Friends of the pancreas,
3rdP ANCREATI CDI SEASECOURSE 4th E USWORKSHOPi npancreati CDI SEASES www. wor k s hoppanc r e as. r o r e. www. panc as r o COURSEDI RECTORS Cr i s t i angheor ghe Mi r c eadi c ul es c u I r i nelpopes
9 th INTERNATIONAL CONFERENCE
MINISTRY OF NATIONAL EDUCATION AND SCIENTIFIC RESEARCH UNIVERSITY SPIRU HARET PHYSICAL EDUCATION AND SPORT FACULTY UNIVERSITY OF CRAIOVA PHYSICAL EDUCATION AND SPORT FACULTY Facultatea de de Educaţie Fizică
What s a Transplant? What s not?
What s a Transplant? What s not? How to report the difference? Daniel Weisdorf MD University of Minnesota Anti-cancer effects of BMT or PBSCT [HSCT] Kill the cancer Save the patient Restore immunocompetence
DETERMINANT VALUE OF THE CYTOGENETIC AND MOLECULAR IMATINIB THERAPEUTIC RESPONSE IN CHRONIC MYELOID LEUKEMIA
Analele Ştiinţifice ale Universităţii Alexandru Ioan Cuza, Secţiunea Genetică şi Biologie Moleculară, TOM XIV, 2013 DETERMINANT VALUE OF THE CYTOGENETIC AND MOLECULAR IMATINIB THERAPEUTIC RESPONSE IN CHRONIC
Leukine. Leukine (sargramostim) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)
8 th INTERNATIONAL CONFERENCE
MINISTRY OF NATIONAL EDUCATION AND SCIENTIFIC RESEARCH UNIVERSITY SPIRU HARET PHYSICAL EDUCATION AND SPORT FACULTY UNIVERSITY OF CRAIOVA PHYSICAL EDUCATION AND SPORT FACULTY Facultatea de de Educaţie Fizică
Viorel LUPU * Romania
Viorel LUPU * Romania Izabela Ramona LUPU * * * Associate Professor to the Department of Psychiatry & Child and Adolescent Psychiatry M.D., Ph. D. Iuliu Haţieganu University of Medicine and Pharmacy e-mail:
Stem Cell Transplantation for Severe Aplastic Anemia
Number of Transplants 10/24/2011 Stem Cell Transplantation for Severe Aplastic Anemia Claudio Anasetti, MD Professor of Oncology and Medicine Chair, Blood and Marrow Transplant Dpt Moffitt Cancer Center
Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:
Medical Policy Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Type: Medical Necessity and Investigational / Experimental Policy Specific Section:
What s new in Blood and Marrow Transplant? Saar Gill, MD PhD Jan 22, 2016
What s new in Blood and Marrow Transplant? Saar Gill, MD PhD Jan 22, 2016 Division of Hematology-Oncology University of Pennsylvania Perelman School of Medicine 1 Who should be transplanted and how? Updates
The Blood and Marrow. Transplant Program at Northside Hospital 30%
IN THIS ISSUE: SPRING 12 www.bmtga.com www.northside.com The Blood and Marrow News Transplant Program at Northside Hospital Research Updates HLA-identical Relatives are Suitable Alternative Donors for
BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016
BMTCN Review Course Basic Concepts and Indications for Transplantation How the Experts Treat Hematologic Malignancies Las Vegas, NV, March 10, 2016 David Rice, PhD, RN, NP Director, Professional Practice
The National Marrow Donor Program. Graft Sources for Hematopoietic Cell Transplantation. Simon Bostic, URD Transplant Recipient
1988 199 1992 1994 1996 1998 2 22 24 26 28 21 212 214 216 218 Adult Donors Cord Blood Units The National Donor Program Graft Sources for Hematopoietic Cell Transplantation Dennis L. Confer, MD Chief Medical
An Overview of Blood and Marrow Transplantation
An Overview of Blood and Marrow Transplantation October 24, 2009 Stephen Couban Department of Medicine Dalhousie University Objectives What are the types of blood and marrow transplantation? Who may benefit
Haploidentical Transplantation: The Answer to our Donor Problems? Mary M. Horowitz, MD, MS CIBMTR, Medical College of Wisconsin January 2017
Haploidentical Transplantation: The Answer to our Donor Problems? Mary M. Horowitz, MD, MS CIBMTR, Medical College of Wisconsin January 2017 Allogeneic Transplant Recipients in the US, by Donor Type 9000
OCULAR SURFACE PROTECTION CONTACT LENSES - NEWS
SCIENTIFIC PROGRAMME OCULAR SURFACE PROTECTION CONTACT LENSES - NEWS FRIDAY, 03.11.2017 08.30 9.00 OPENING CEREMONY 09.00 9.30 WELCOME MICRO COURSE REGARDING OCULAR SURFACE PROTECTION Chairpersons: Cătălina
4nd Patient and Family Day
4nd Patient and Family Day EBMT Slide template Barcelona 7 February 2008 EBMT 2010 Vienna, Austria ; www.ebmt.org History of Stem Cell Transplantation Appelbaum et al, NEJM 2006 What is EBMT? Scientific,
R J M E Romanian Journal of Morphology & Embryology
Rom J Morphol Embryol 2016, 57(2):551 557 CASE REPORT R J M E Romanian Journal of Morphology & Embryology http://www.rjme.ro/ Hemophagocytic lymphohistiocytosis: a rare complication of autologous stem
The Immunobiology Working Party
The Immunobiology Working Party Educational Event 28-29 September 2013,, Italy Faculty of Medicine, University of Chairman: Andrea Velardi I am happy to announce the upcoming EBMT Immunobiology Working
Trends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014
Trends in Hematopoietic Cell Transplantation AAMAC Patient Education Day Oct 2014 Objectives Review the principles behind allogeneic stem cell transplantation Outline the process of transplant, some of
Carol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT
Carol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT History Why is blood transfusion involved? What tests are performed in blood transfusion and why? What does a protocol look
5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow
5/9/2018 or Stem Cell Harvest Where we are now, and What s Coming AA MDS International Foundation Indianapolis IN Luke Akard MD May 19, 2018 Infusion Transplant Conditioning Treatment 2-7 days STEM CELL
Research and Education in an Innovation Era
Education and Sport INTERNATIONAL SYMPOSIUM Research and Education in an Innovation Era 6 th Edition, 8 th 10 th of December 2016, ARAD Programme of the Physical Education and Sport Section: Health related
Summary of Accomplishments As of 1/31/17
Summary of Accomplishments As of 1/31/17 VALUE TO THE HCT COMMUNITY The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) plays a critical role in improving patient outcomes and advancing the
Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand
Appendix 6: Indications for adult allogeneic bone marrow transplant in New Zealand This list provides indications for the majority of adult BMTs that are performed in New Zealand. A small number of BMTs
Lista candidatilor admisi in sesiunea
1. IE26 Aleman D. Bogdan Dan 7.67 10.00 8.83 IE3 : buget 2. IE10 Andreica G. Ciprian 9.08 10.00 9.54 IE3 : buget 3. IE16 Ardelean D. Paul Marian 9.86 10.00 9.93 IE3 : buget 4. IE125 Arpastoan - Ionuta
October 17 20, 2018 New York City. An International Congress on Lymphoma, Myeloma, and Leukemia Disorders
An International Congress on Lymphoma, Myeloma, and Leukemia Disorders NEW DAY! New Approaches in Acute Leukemias and Hematologic Malignancies Wednesday, October 17 October 17 20, 2018 New York City lymphomaandmyeloma.com
UPDATE Autologous Stem Cell Transplantation for Lymphoma and Myeloma
UPDATE Autologous Stem Cell Transplantation for Lymphoma and Myeloma Supported by a grant from Supported by a grant from UPDATE Autologous Stem Cell Transplantation for Lymphoma and Myeloma Jonathan W.
CONSIDERATIONS IN DESIGNING ACUTE GVHD PREVENTION TRIALS: Patient Selection, Concomitant Treatments, Selecting and Assessing Endpoints
CONSIDERATIONS IN DESIGNING ACUTE GVHD PREVENTION TRIALS: Patient Selection, Concomitant Treatments, Selecting and Assessing Endpoints CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH Potential
Lynn B. Bonifacio, MD, FPCP, DPSHBT National Kidney and Transplant Institute Philippines
Lynn B. Bonifacio, MD, FPCP, DPSHBT National Kidney and Transplant Institute Philippines 3. WBMT Workshop 14-15 November 2014 Cape Town, South Africa Department for Hematology and Medical Oncology Leipzig,
EBV in HSCT 2015 update of ECIL guidelines
ECIL-6 EBV in HSCT 2015 update of ECIL guidelines Jan Styczynski (Poland, chair), Walter van der Velden (Netherlands), Christopher Fox (United Kingdom), Dan Engelhard (Israel), Rafael de la Camara (Spain),
Volume 54 Number 2, 2013 (new series) ROMANIAN JOURNAL MORPHOLOGY AND EMBRYOLOGY ROMANIAN ACADEMY PUBLISHING HOUSE
Volume 54 Number 2, 2013 (new series) ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY ROMANIAN ACADEMY PUBLISHING HOUSE 2013 ROMANIAN ACADEMY PUBLISHING HOUSE. All rights reserved. ROMANIAN ACADEMY PUBLISHING
Summary of Changes Page BMT CTN 1205 Protocol Amendment #4 (Version 5.0) Dated July 22, 2016
Page 1 of 8 Date: July 22, 2016 Summary of Changes Page BMT CTN 1205 Protocol #4 Dated July 22, 2016 The following changes, and the rationale for the changes, were made to the attached protocol in this
Stem cells. -Dr Dinesh Bhurani, MD, DM, FRCPA. Rajiv Gandhi Cancer Institute, Delhi, -Director, Department of Haematology and BMT
Stem cells -Dr Dinesh Bhurani, MD, DM, FRCPA -Director, Department of Haematology and BMT Rajiv Gandhi Cancer Institute, Delhi, Flow of presentation Update on stem cell uses Haematopoietic stem cell transplantation
YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY
1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor
THE LEUKEMIAS. Etiology:
The Leukemias THE LEUKEMIAS Definition 1: malignant transformation of the pluripotent stem cell, successive expansion of the malignant clone from the bone marrow to the tissues Definition 2: Heterogenous
Hematopoietic Cell Transplantation for Myelofibrosis. Outline
Hematopoietic Cell Transplantation for Myelofibrosis H.Joachim Deeg MD Fred Hutchinson Cancer Research Center & University of Washington, Seattle WA Great Debates, NY, 4/28/2012 Outline Rationale for hematopoietic
NEWS FROM. Roswell Park s BLOOD AND MARROW TRANSPLANT PROGRAM
NEWS FROM Roswell Park s BLOOD AND MARROW TRANSPLANT PROGRAM THE BLOOD AND MARROW TRANSPLANT TEAM Philip McCarthy, MD Medical Director, BMT Program Hong Liu, MD, PhD Attending Physician Our multidisciplinary
Bone Marrow Transplantation in Myelodysplastic Syndromes. An overview for the Myelodysplasia Support Group of Ottawa
Bone Marrow Transplantation in Myelodysplastic Syndromes An overview for the Myelodysplasia Support Group of Ottawa Objectives Provide brief review of marrow failure Re emphasize the importance of predictions
SCIENTIFIC TIMETABLE SIOP 2015
SCIENTIFIC TIMETABLE SIOP 2015 September, 2015 WEDNESDAY, 7 TH OCTOBER 2015 / DAY 2 1.43 09:30 SIOP Committee 12:00 SIOP Essential Drugs Working 13:00 SIOP Work (Open) 14:00 Nurse Researchers 16:00 17:00
Summary of Accomplishments As of 1/31/18
Summary of Accomplishments As of 1/31/18 VALUE TO THE HCT COMMUNITY The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) plays a critical role in improving patient outcomes and advancing the
Kymriah. Kymriah (tisagenlecleucel) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.101 Subject: Kymriah Page: 1 of 5 Last Review Date: September 20, 2018 Kymriah Description Kymriah
THE 5TH INTERNATIONAL COURSE AND WORKSHOP ON ADVANCED LAPAROSCOPIC UROLOGY
THE 5TH INTERNATIONAL COURSE AND WORKSHOP ON ADVANCED LAPAROSCOPIC UROLOGY THE 33RD INTERNATIONAL TURKUROLAP COURSE 8-10 OCTOBER 2015 www.cleru.ro THIS EVENT IS CREDITED WITH EMC AND EU-ACME POINTS 8-10
Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017
Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis
HEMATOLOGY & BLOOD TRANSFUSION
The Ninth Regional Meeting of The Lebanese Society of HEMATOLOGY & BLOOD TRANSFUSION October 1-3, 2015 Hilton Metropolitan Hotel, Beirut-Lebanon CME CREDITS Welcome Letter Dear Colleagues, I am pleased
Hematopoietic Stem Cell Transplant in Sickle Cell Disease- An update
Hematopoietic Stem Cell Transplant in Sickle Cell Disease- An update Dr Chirag A Shah Diplomate American Board of Hematology and Medical Oncology Director, Dept of Hemato-Oncology and Stem Cell Transplant
The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:
Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist
Development of multidisciplinary innovative strategies for the care of the Romanian individual with cleft lip and/or palate
Development of multidisciplinary innovative strategies for the care of the Romanian individual with cleft lip and/or palate Bucharest, September 22 nd 24 th, 2014 Monday 22.09.2014 08.30-09.00 Registration
Therapeutic Advances in Treatment of Aplastic Anemia. Seiji Kojima MD. PhD.
Therapeutic Advances in Treatment of Aplastic Anemia Seiji Kojima MD. PhD. Department of Pediatrics Nagoya University Graduate School of Medicine Chairman of the Severe Aplastic Anemia Working Party Asia-Pacific
Introduction to Hematopoietic Stem Cell Transplantation
Faculty Disclosures Introduction to Hematopoietic Stem Cell Transplantation Nothing to disclose Jeanne McCarthy-Kaiser, PharmD, BCOP Clinical Pharmacist, Autologous Stem Cell Transplant/Long- Term Follow-Up
Faculty of Physical Education and Sport
Faculty of Physical Education and Sport Organizing Committee: Prof. Liviu Vasile Andrei, PhD Dean, Prof. Viorel Bitang, PhD, Prof. Ioan Dorin Galea, PhD, Assoc. Prof. Corina Dulceanu, PhD, Assist. Prof.
T cell manipulation of the graft: Yes
T cell manipulation of the graft: Yes J.H. Frederik Falkenburg Department of Hematology L M U C Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for non-malignant disorders: no need for anti-tumor
Dr.PSRK.Sastry MD, ECMO
Peripheral blood stem cell transplantation (Haematopoietic stem cell transplantation) Dr.PSRK.Sastry MD, ECMO Consultant, Medical Oncology Kokilaben Dhirubhai Ambani Hospital Normal hematopoiesis Historical
DEPARTMENT OF CLINICAL HEMATOLOGY
DEPARTMENT OF CLINICAL HEMATOLOGY What is blood? Blood is the vital fluid of the body, which performs diverse functions from delivering oxygen to each and every cell of the body to fighting against infections
PUBLICATIONS. Title: GENETIC TECHNOLOGIES IN CANCER INVESTIGATION APPLICATIONS IN AGGRESIVE LYMPHOID MALIGNANCIES.
PUBLICATIONS ARTICLES: Title: MOLECULAR CHARACTERIZATION OF COMPLEX CHROMOSOMAL CHANGES IN DE NOVO ACUTE MYELOID LEUKEMIA: A CASE REPORT. Author(s): Nicoleta P. Berbec, Sorina M.F. Papuc, Andreea C.D.F.
Hematologic Malignancies 2013 Retrospective Study at Truman Medical Center
Hematologic Malignancies 2013 Retrospective Study at Truman Medical Center Kristen Strasser, MD & Abdulraheem Qasem, MD Introduction: Hematologic Malignancies includes malignant diseases of the bone marrow
AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)
AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa
FILE - STEM CELL TRANSPLANT FOR MDS ARCHIVE
06 February, 2018 FILE - STEM CELL TRANSPLANT FOR MDS ARCHIVE Document Filetype: PDF 497.57 KB 0 FILE - STEM CELL TRANSPLANT FOR MDS ARCHIVE Allogeneic hematopoietic stem-cell transplantation (HSCT) is
Bone Marrow Transplantation and the Potential Role of Iomab-B
Bone Marrow Transplantation and the Potential Role of Iomab-B Hillard M. Lazarus, MD, FACP Professor of Medicine, Director of Novel Cell Therapy Case Western Reserve University 1 Hematopoietic Cell Transplantation
Understanding the role of ex vivo T cell depletion
Prevention of graftversus-host disease (GVHD) Understanding the role of ex vivo T cell depletion Information for patients undergoing allogeneic stem cell transplantation in AML and their families 2 This
Haplo vs Cord vs URD Debate
3rd Annual ASBMT Regional Conference for NPs, PAs and Fellows Haplo vs Cord vs URD Debate Claudio G. Brunstein Associate Professor University of Minnesota Medical School Take home message Finding a donor
Haploidentical Stem Cell Transplantation with post transplantation Cyclophosphamide for the treatment of Fanconi Anemia
Haploidentical Stem Cell Transplantation with post transplantation Cyclophosphamide for the treatment of Fanconi Anemia Carmem Bonfim Director Pediatric Blood and Marrow Transplantation Program HC Federal
Relapse After Transplant: Next Steps for Patients with Hodgkin Lymphoma
Hi! My name is Alison Moskowitz. I am an attending at Memorial Sloan Kettering Cancer Center within the Lymphoma Department. I am speaking on behalf of ManagingHodgkinLymphoma.com. I will be discussing
The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
VOLUME 46 ㆍ NUMBER ㆍ March 0 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children Meerim Park, Kyung
High dose cyclophosphamide in HLAhaploidentical
High dose cyclophosphamide in HLAhaploidentical stem cell transplantation Ephraim J. Fuchs, M.D., M.B.A. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins fuchsep@jhmi.edu Alternative Donor Transplantation:
Trends in Hematopoietic Stem Cell Transplant Activity in Lebanon ( )
Trends in Hematopoietic Stem Cell Transplant Activity in Lebanon (2012 2016) Ali Bazarbachi, MD, PhD Associate Dean for Basic Research Professor of Medicine, Hematology and Oncology Professor of Anatomy,
TRESTIOREANU CONFERENCE ROOM october 26 th
TRESTIOREANU CONFERENCE ROOM october 26 th BREAST IMAGING COURSE 8.00 8.50 8.50 9.00 9.00 9.25 Prof. Dr. Alexandru Blidaru Welcome and opening remarks Assist. Prof. Dr. Ștefan Voiculescu Anatomy of the
AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)
AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa
ELENA CINTEZA EDITORIAL COUNCIL 1. MONICA ACALOVSCHI 2. DINU ANTONESCU 3. VASILE ASTARASTOAIE 4. RADU BADEA
Volume 7 No. 2 2012 Editor-in-Chief MIRCEA CINTEZA Senior Editor ALAIN CARPENTIER Paris Deputy Editors ADRIAN COVIC Iasi DRAGOS VINEREANU Bucharest Editorial Board Secretary ELIZA ELENA CINTEZA Bucharest
Pediatric Hematopoietic Stem Cell Transplant - Experience of an Indian Tertiary Care Center
Pediatric Hematopoietic Stem Cell Transplant - Experience of an Indian Tertiary Care Center Dr Chirag A Shah Diplomate American Board of Hematology and Medical Oncology Director, Dept of Hemato-Oncology
FIZIOLOGIA (PHYSIOLOGY) 2006; vol.16, nr. 3 (51) CONTENTS
FIZIOLOGIA (PHYSIOLOGY) 2006; vol.16, nr. 3 (51) CONTENTS 1. Changes in Serum Levels of Reactive Oxygen Species, Antioxidants and Nitric Oxide during Normal Pregnancy Lavinia I Sabau, Soimita Suiciu, Adriana
Le infezioni fungine nel trapianto di cellule staminali emopoietiche. Claudio Viscoli Professor of Infectious Disease University of Genova, Italy
Le infezioni fungine nel trapianto di cellule staminali emopoietiche Claudio Viscoli Professor of Infectious Disease University of Genova, Italy Potential conflicts of interest Received grants as speaker/moderator
Systematic Reviews in Hematological Malignancies
Systematic Reviews in Hematological Malignancies Pia Raanani, MD Davidoff Cancer Center Rabin Medical Center, Israel 1 2 Disorder CHMG Systematic review* Title Protocol Full Review Myelodysplastic syndrome
Editor-in-Chief Daniel Coriu University of Pharmacy Carol Davila Bucharest, Fundeni Institute, Bucharest, Romania
1 Editor-in-Chief Daniel Coriu University of Pharmacy Carol Davila Bucharest, Fundeni Institute, Bucharest, Romania Deputy/ Managing Editor Radu Niculescu, Fundeni Clinical Institute, Bucharest, Romania
Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen
Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells
RCCC Romanian Crohn`s
RCCC Romanian Crohn`s and Colitis Club 8 th National Symposium on Inflammatory Bowel Diseases 29 th of September - 1 st of October 2016 Crowne Plaza Bucharest, Romania President Mircea Diculescu Organizing
Pediatric Hematology-Oncology
Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS
Program Schedule Clinical Multidisciplinary Hematology & Oncology: The 16 th Annual Review
Program Schedule Clinical Multidisciplinary Hematology & Oncology: The 16 th Annual Review Friday, February 15, 2019 6:45 a.m. Registration, Breakfast and Exhibits 7:30 a.m. Welcome and Introductions SESSION
Blood & Marrow Transplantation Center
Blood & Marrow Transplantation Center We were one of the first centers in the world to routinely offer patients blood and marrow transplantation (BMT). What Sets Us Apart High-volume center performs about
Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint
Bone Marrow Protocol applies to acute leukemias, myelodysplastic syndromes, myeloproliferative disorders, chronic lymphoproliferative disorders, malignant lymphomas, plasma cell dyscrasias, histiocytic
املؤمتر الدويل الرابع لجمعية امراض الدم األردنية
The 4 th International Conference of the Jordanian Society of Hematology املؤمتر الدويل الرابع لجمعية امراض الدم األردنية Jordanian Society of Hematology February 10 th - 12 th, 2016 Le Royal Hotel Amman,